News | June 05, 2021
Jubilant Pharmova posts Q4FY21 consolidated PAT of Rs. 213.90 Cr
The company is doubling its chemistry research capacity that should commission by Q2'FY22
The company is doubling its chemistry research capacity that should commission by Q2'FY22
The company reported total income of Rs.634.79 crores during the 12 months period ended March 31, 2021
The company has posted net profit of Rs.147.78 crores for the 12 months period ended March 31, 2021
Adjusted PAT declined 18.8% YoY
The company reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021
India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
The GMP certificate is valid for three years until April 2024.
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
Subscribe To Our Newsletter & Stay Updated
